Vitamin D Protects Against Alcohol‐Induced Liver Cell Injury Within an NRF2–ALDH2 Feedback Loop

Molecular Nutrition and Food Research - Tập 63 Số 6 - 2019
Hong Zhang1, Lian Xue1, Bingyan Li2, Zengli Zhang1, Shasha Tao3,1
1School of Public Health, Medical College of Soochow University, 199 Ren'ai Road, Suzhou 215123, Jiangsu, China
2Experimental Center of Medical College, Soochow University, 199 Ren'ai Road, Suzhou, 215123 Jiangsu, China
3J. Key Laboratory of Preventive and Translational Medicine for Geriatric Disease, School of Public Health, Soochow University, Suzhou, 215123 PR China

Tóm tắt

ScopeAlcoholic liver disease (ALD) is a major cause of morbidity and mortality worldwide. Oxidative stress induced during the alcohol metabolism plays a crucial role in ALD, and clinical evidence demonstrates the prevalence and risks of vitamin D (VD) deficiency in ALD. This study aims to explore the mechanism of VD administration to ameliorate alcohol‐induced cell injury.Methods and resultsVD activates NRF2 (nuclear factor erythroid 2 (NF‐E2)‐related factor 2) signals along with upregulation of ALDH2 expression. Knockdown of NRF2 eliminates the protective effects of VD treatment. ALDH2 knockdown not only partially affects this protection, but also mildly reduces NRF2 expression. ALDH2 overexpression enhances ERK phosphorylation and upregulated NRF2 transcription via a newly identified TRE in the exon 1 of NRF2.ConclusionThis study provides evidence that VD protects against alcohol‐induced cell injury within an NRF2‐ALDH2 feedback loop. NRF2 induced by VD could transcriptionally upregulate ALDH2 expression to help metabolize alcohol. TRE‐driven transcriptional upregulation of NRF2 through ALDH2‐ERK/MEK signals would further exert the anti‐oxidant effects. The study explores a novel potential protection of VD in alcohol‐induced liver cell injury, and contributes to alcohol‐related liver disease nutritional therapies.

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(09)60746-7

10.1053/j.gastro.2011.09.002

10.1111/jgh.12030

10.1194/jlr.M056978

10.1515/bc.2010.137

10.1007/s12011-016-0821-1

10.1101/gad.225680.113

10.1080/03602530600971974

10.1146/annurev.pharmtox.46.120604.141046

10.1158/1055-9965.EPI-09-1121

10.1007/s12263-009-0154-1

10.1038/nrc2191

10.1186/1479-7364-2-2-138

10.1152/physrev.00017.2013

10.1371/journal.pone.0080158

10.1016/j.bbadis.2014.05.017

10.1371/journal.pone.0088779

Yukawa Y., 2014, Am. J. Cancer Res., 4, 279

10.1038/aps.2010.203

10.3122/jabfm.2009.06.090037

10.1055/s-0044-101355

10.1139/bcb-2016-0070

10.1507/endocrj.EJ16-0542

10.1016/j.bbrc.2015.06.011

10.1158/0008-5472.CAN-14-1439

10.1002/jbt.21463

10.1089/ars.2012.5117

Chen L., 2018, Int. J. Cancer

10.1097/00008571-199204000-00002

10.1002/em.21824

10.1016/j.bbrc.2010.11.131

10.1111/j.1582-4934.2011.01347.x

10.1093/alcalc/agt063

10.1074/jbc.M308011200

10.1016/j.yjmcc.2005.11.006

10.1126/science.1158554

10.1038/nsmb.1737

10.4161/auto.6.8.13652

10.1016/j.phrs.2008.09.003

10.1016/j.molcel.2006.01.013

10.1038/nrc3262

10.1038/nature10189

10.1016/j.freeradbiomed.2012.11.010

10.1016/j.cbi.2011.10.007